Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Fig. 4

Risk score analysis of the prognostic signature in the training cohort. A–C The risk score distribution, survival status, expression heatmap of nine immune-related eRNAs between high- and low-risk groups in the training set. D Kaplan–Meier survival curve analysis of OS in high- and low-risk groups. E Time-dependent ROC curve analysis of the prognostic signature. F PCA analysis in high- and low-risk groups

Back to article page